Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Merck Made a Mistake by Selling Its Moderna Stake

TheMotleyFool

0 0

Here's Why Merck Made a Mistake by Selling Its Moderna Stake

Merck (NYSE: MRK) was one of the earliest investors in Moderna (NASDAQ: MRNA), buying a position in the biotech even before it went public in late 2018. Earlier this month, though, Merck announced that it had sold all of its shares of Moderna, making a sizable profit. In this Motley Fool Live video recorded on Dec. 9, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights discuss why it appears that Merck made a mistake by selling its Moderna stake.

Source Fool.com

Like: 0

MRNA

Share